Endometrial Cancer 2022
DOI: 10.1136/ijgc-2022-esgo.304
|View full text |Cite
|
Sign up to set email alerts
|

2022-RA-1314-ESGO Evaluation of the concentration of the soluble form of programmed cell death-ligand 2 in patients with endometrial cancer

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles